MacroGenics
MGNX
#9452
Rank
S$0.16 B
Marketcap
S$2.53
Share price
-1.01%
Change (1 day)
36.20%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): S-$0.72

According to MacroGenics's latest financial reports the company's current EPS (TTM) is S-$0.74. In 2025 the company made an earnings per share (EPS) of S-$1.52 a decrease over its 2024 EPS that were of S-$1.38.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.72-52.72%
2025S-$1.5210.28%
2024S-$1.38613.33%
2023S-$0.19-92.31%
2022S-$2.52-42.14%
2021S-$4.3536.44%
2020S-$3.19-21.84%
2019S-$4.08-24.58%
2018S-$5.41675.93%
2017S-$0.70-68.05%
2016S-$2.18168.25%
2015S-$0.81-55%
2014S-$1.813400%
2013S-$0.05160-108.68%
2012S$0.5924.49%
2011S$0.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.92-224.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.85-5,519.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$22.42-3,149.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S-$4.00 443.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.28-274.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.83-892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S-$2.03 175.44%๐Ÿ‡บ๐Ÿ‡ธ USA